The closing of this transaction is subject to the normal due diligence process.

‘The closing of this transaction is subject to the normal due diligence process, mentioned B. Michael Friedman, co-founder and acting CEO of Cannabis Medical Solutions, including, without limitation, the execution of a definitive contract and compliance with state and federal laws and regulations.. CMSI signs Letter of Intent with Green Medicals to acquire equity interest in 8 medical marijuana dispensaries Cannabis Medical Solutions Inc. , a respected company specializing in both brick-and-mortar and online merchant payment solutions and financial security items for medical marijuana dispensaries and high-risk merchant accounts, today announced that the business has signed a Letter of Intent with Green Medicals LLC to acquire equity curiosity in up to eight medical marijuana dispensaries within the state of Colorado.It’s estimated that one in three people die of tumor, 90 percent which from tumors which have spread and be resistant to treatment. Numerous studies show that the Axl receptor kinase is usually closely associated with drug resistance and medications that inhibit it might provide a promising potential brand-new treatment option. Analysis by BerGenBio in the advancement of BGB324, the Business's first-in-course selective Axl kinase inhibitor, provides firmly established the idea that inhibition of the Axl/EMT pathway works well against acquired medication resistant and aggressive cancers and in addition has identified new methods to inhibiting EMT.